多基因评分与精神障碍年龄特异性风险的性别差异关联
该研究基于丹麦iPSYCH2015病例-队列样本,分析五种精神障碍的多基因评分(PGS)与年龄和性别特异性诊断风险的关联。结果显示所有PGS与所有障碍风险相关,且关联在较年轻年龄更强,并呈现性别特异性模式。
要点
- MDD的PGS在17-19岁关联最强,男性HR 1.56,女性HR 1.48。
- SCZ的PGS关联存在性别差异,男性20-22岁HR 1.71,女性17-19岁HR 1.29。
- ASD的PGS在男性4-6岁和7-9岁关联最强,女性13-15岁关联最强。
核心结论
- 精神障碍的多基因负担与诊断风险的关联在较年轻年龄更强,并呈现性别特异性模式。
研究设计与样本
- 基于丹麦iPSYCH2015样本的 population-based 病例-队列研究,纳入1981-2008年出生个体,随访1994-2015年。
- 病例包括MDD(N=30 905)、SCZ(N=12 703)、双相障碍(N=3169)、ADHD(N=25 167)和ASD(N=15 677),另随机抽取子队列(N=52 765)。
- 暴露为障碍特异性PGS,使用Cox比例风险模型估计首次医院诊断的性别和年龄特异性风险比。
主要发现
- 所有PGS与所有障碍风险相关, regardless of age。
- MDD的PGS每增加1个标准差,在17-19岁关联最高:男性HR 1.56(95% CI 1.45-1.69),女性HR 1.48(95% CI 1.40-1.57)。
- SCZ的PGS与SCZ诊断关联在男性20-22岁最强(HR 1.71;95% CI 1.54-1.90),女性17-19岁最强(HR 1.29;95% CI 1.16-1.44)。
- ASD的PGS关联在男性4-6岁(HR 1.51;95% CI 1.44-1.61)和7-9岁(HR 1.55;95% CI 1.47-1.65)最强,女性13-15岁最强(HR 1.60;95% CI 1.41-1.82)。
- PGS-精神分裂症关联在男性更强,而儿童期起病障碍的关联在女性更强但出现年龄较晚。
临床怎么用
- 未来遗传研究应考虑诊断年龄和潜在性别差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polygenic scores (PGS) have been used to quantify genetic liability for psychiatric disorders, but it remains unclear how these scores are associated with age- and gender-specific risk of diagnosis. AIMS: To examine associations between disorder-specific PGS and age- and gender-specific risk of psychiatric diagnoses across major psychiatric disorders. METHOD: We conducted a population-based case-cohort study using the Danish iPSYCH2015 sample, including individuals born in Denmark between 1981 and 2008 and followed for psychiatric diagnoses from 1994 to 2015. Cases comprised individuals diagnosed with major depressive disorder (MDD; N = 30 905), schizophrenia spectrum disorders (SCZ; N = 12 703), bipolar disorder (N = 3169), attention-deficit hyperactivity disorder (N = 25 167) or autism spectrum disorder (ASD; N = 15 677), alongside a randomly sampled subcohort (N = 52 765). Disorder-specific PGS were the exposures. Gender- and age-specific hazard ratios for first hospital-based diagnoses were estimated using Cox proportional hazards models. RESULTS: All PGS were associated with risk of all disorders regardless of age. For MDD, the highest association per 1 s.d. increase in PGS was observed at ages 17-19 (males: hazard ratio 1.56; 95% CI 1.45-1.69; females: hazard ratio 1.48; 95% CI 1.40-1.57). SCZ-PGS showed marked gender differences, with the strongest association with SCZ diagnosis at ages 20-22 years for males (hazard ratio 1.71; 95% CI 1.54-1.90) and 17-19 years for females (hazard ratio 1.29; 95% CI 1.16-1.44). ASD-PGS associations were strongest in males at ages 4-6 (hazard ratio 1.51; 95% CI 1.44-1.61) and 7-9 years (hazard ratio 1.55; 95% CI 1.47-1.65), and in females at ages 13-15 years (hazard ratio 1.60; 95% CI 1.41-1.82). Gender differences were evident across disorders. The PGS-schizophrenia association was stronger in males, whereas for childhood-onset disorders, associations were stronger in females but emerged at older ages. CONCLUSIONS: Polygenic burden for psychiatric disorders tends to be more strongly associated with risk of diagnosis at younger ages, with gender-specific patterns. Future genetic research should consider both age at diagnosis and potential gender differences.
引用
- Maseras GT, Chen D, Albiñana C, et al. Gender-specific associations between polygenic scores and age-specific risk of psychiatric disorders. Br J Psychiatry. 2026. PMID: 42803346. doi:10.1192/bjp.2026.10759
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。